(Q42486918)

1 November 2017

title

Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin (English)

1 reference

1 November 2017

1 reference

1 reference

1 reference

Brasanac D

1

1 reference

1 November 2017

Boricic I

2

1 reference

1 November 2017

Todorovic V

3

1 reference

1 November 2017

Tomanovic N

4

1 reference

1 November 2017

Radojevic S

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

British Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

153

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

1166-1175

1 reference

Ki67 protein: the immaculate deception?

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Cyclin A in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Association between histology grade, expression of HsMCM2, and cyclin A in human invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

A novel immunohistochemical method to estimate cell‐cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Expression of cyclin A in Merkel cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Convergence of Wnt, beta-catenin, and cadherin pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Alteration of beta-catenin expression in esophageal squamous-cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

E-cadherin and catenins in early squamous cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

beta-Catenin expression in the transitional cell zone of pilomatricoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Expression of beta-catenin in basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

High rate of malignant transformation in hyperkeratotic actinic keratoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

The scientific basis of skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

The nature of solar keratosis: a critical review in historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

An actinic keratosis is neither malignant nor premalignant: it is an initiated tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Clinical presentation of actinic keratoses and squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

The actinic (solar) keratosis: a 21st-century perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

From actinic keratosis to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Immunohistochemical study of cell cycle regulatory proteins in intraductal breast carcinomas--a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06898.X

10.1111/J.1365-2133.2005.06898.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference